Zurcher Kantonalbank (Zurich Cantonalbank) Coherus Bio Sciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 10,613 shares of CHRS stock, worth $18,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,613

Previous 10,613 -0.0%

Holding current value

$18,148

Previous $11,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$0.99 - $1.8 $2,891 - $5,257	-2,921 Reduced 21.58%	10,613 $11,000
Q2 2024 Jul 29, 2024	SELL	$1.58 - $2.51 $3,141 - $4,989	-1,988 Reduced 12.81%	13,534 $23,000
Q1 2024 Apr 25, 2024	SELL	$2.02 - $3.14 $42,826 - $66,571	-21,201 Reduced 57.73%	15,522 $37,000
Q4 2023 Jan 30, 2024	BUY	$1.59 - $3.85 $16,278 - $39,416	10,238 Added 38.66%	36,723 $122,000
Q3 2023 Oct 25, 2023	SELL	$3.74 - $5.45 $7,880 - $11,483	-2,107 Reduced 7.37%	26,485 $99,000
Q2 2023 Aug 07, 2023	BUY	$3.79 - $8.3 $170 - $373	45 Added 0.16%	28,592 $122,000
Q1 2023 May 08, 2023	SELL	$5.89 - $10.52 $9,724 - $17,368	-1,651 Reduced 5.47%	28,547 $195,000
Q4 2022 Feb 01, 2023	SELL	$5.69 - $10.07 $2,037 - $3,605	-358 Reduced 1.17%	30,198 $239,000
Q3 2022 Nov 09, 2022	SELL	$7.17 - $13.87 $9,170 - $17,739	-1,279 Reduced 4.02%	30,556 $294,000
Q2 2022 Aug 09, 2022	SELL	$5.86 - $13.23 $8,379 - $18,918	-1,430 Reduced 4.3%	31,835 $230,000
Q1 2022 Apr 21, 2022	BUY	$10.92 - $16.41 $11,673 - $17,542	1,069 Added 3.32%	33,265 $429,000
Q4 2021 Feb 01, 2022	BUY	$15.81 - $18.99 $2,988 - $3,589	189 Added 0.59%	32,196 $514,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $6,897 - $9,677	-544 Reduced 1.67%	32,007 $514,000
Q2 2021 Jul 30, 2021	BUY	$12.95 - $15.41 $15,203 - $18,091	1,174 Added 3.74%	32,551 $450,000
Q1 2021 May 03, 2021	BUY	$14.42 - $21.39 $318,206 - $472,013	22,067 Added 237.02%	31,377 $458,000
Q2 2020 Jul 28, 2020	BUY	$14.43 - $19.16 $67,719 - $89,917	4,693 Added 101.65%	9,310 $166,000
Q1 2020 May 06, 2020	BUY	$11.67 - $22.53 $11,553 - $22,304	990 Added 27.3%	4,617 $75,000
Q1 2019 Apr 29, 2019	BUY	$8.38 - $15.5 $2,731 - $5,053	326 Added 9.88%	3,627 $49,000
Q3 2018 Nov 09, 2018	BUY	$14.45 - $20.25 $6,589 - $9,234	456 Added 16.03%	3,301 $54,000
Q2 2018 Aug 06, 2018	BUY	$10.25 - $17.45 $23,001 - $39,157	2,244 Added 373.38%	2,845 $40,000
Q3 2017 Nov 08, 2017	BUY	$11.1 - $14.5 $6,671 - $8,714	601	601 $8,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $133M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Coherus Bio Sciences, Inc. Transaction History